Cargando…

Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5

Pulmonary fibrosis is a serious disease characterized by extracellular matrix (ECM) component overproduction and remodeling. Insulin-like growth factor-binding protein 5 (IGFBP5) is a conserved member of the IGFBP family of proteins that is overexpressed in fibrotic tissues and promotes fibrosis. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Xinh-Xinh, Renaud, Ludivine, Feghali-Bostwick, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619832/ https://www.ncbi.nlm.nih.gov/pubmed/34830489 http://dx.doi.org/10.3390/ijms222212609

Ejemplares similares

Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2020)

IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2018)

2027 The role of lysyl oxidase in systemic sclerosis-associated lung fibrosis
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2018)

Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4
por: Su, YunYun, et al.
Publicado: (2019)

Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis
por: van de Vlekkert, Diantha, et al.
Publicado: (2019)

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
por: Sharma, Shailza, et al.
Publicado: (2021)

IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF
por: Su, Yunyun, et al.
Publicado: (2015)

Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
por: Renaud, Ludivine, et al.
Publicado: (2020)

Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5
por: Yamaguchi, Yukie, et al.
Publicado: (2011)

The Membrane-Associated Adaptor Protein DOK5 Is Upregulated in Systemic Sclerosis and Associated with IGFBP-5-Induced Fibrosis
por: Yasuoka, Hidekata, et al.
Publicado: (2014)

First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry
por: Renaud, Ludivine, et al.
Publicado: (2023)

Fibroblasts in fibrosis: novel roles and mediators
por: Kendall, Ryan T., et al.
Publicado: (2014)

PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1
por: Takamura, Naoko, et al.
Publicado: (2021)

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
por: Mouawad, Joe E., et al.
Publicado: (2023)

382 The Role of the IL-6-IGF-II Axis in Systemic Sclerosis-Associated Lung Fibrosis
por: Adewale, Adegboyega Timothy, et al.
Publicado: (2023)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis
por: Waldrep, Kristy M., et al.
Publicado: (2023)

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K(Ca)3.1-dependent
por: Roach, Katy M, et al.
Publicado: (2014)

Insulin-Like Growth Factor Binding Proteins-3 and -5: Central Mediators of Fibrosis and Promising New Therapeutic Targets
por: Veraldi, Kristen L, et al.
Publicado: (2012)

The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy Morgan, et al.
Publicado: (2013)

Correction: The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy M, et al.
Publicado: (2014)

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
por: Coward, William R., et al.
Publicado: (2014)

Systems Analysis of Transcriptomic and Proteomic Profiles Identifies Novel Regulation of Fibrotic Programs by miRNAs in Pulmonary Fibrosis Fibroblasts
por: Mullenbrock, Steven, et al.
Publicado: (2018)

Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH)
por: Argula, Rahul G, et al.
Publicado: (2019)

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
por: Wang, Xiao Mei, et al.
Publicado: (2006)

Elucidating the cellular mechanism for E2-induced dermal fibrosis
por: Baker Frost, DeAnna, et al.
Publicado: (2021)

Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis
por: Hadjicharalambous, Marina R., et al.
Publicado: (2019)

Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis
por: Sureshbabu, A., et al.
Publicado: (2011)

Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
por: Garrett, Sara M., et al.
Publicado: (2019)

Glial remodeling enhances short-term memory performance in Wistar rats
por: De Luca, Simone N., et al.
Publicado: (2020)

Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis
por: Artlett, Carol M., et al.
Publicado: (2017)

Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs
por: Matsuda, Shuichi, et al.
Publicado: (2020)

Hyperleptinemia in Neonatally Overfed Female Rats Does Not Dysregulate Feeding Circuitry
por: Ziko, Ilvana, et al.
Publicado: (2017)

Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis
por: Watanabe, Tomoya, et al.
Publicado: (2017)

The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis
por: Kurowska-Stolarska, Mariola, et al.
Publicado: (2017)

Induction of a Th17 Phenotype in Human Skin—A Mimic of Dermal Inflammatory Diseases
por: Garrett, Sara M., et al.
Publicado: (2019)

IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis
por: Liso, Arcangelo, et al.
Publicado: (2022)

Protective effects of Qing-Re-Huo-Xue formula on bleomycin-induced pulmonary fibrosis through the p53/IGFBP3 pathway
por: Yang, Fangyong, et al.
Publicado: (2023)

Genetics of systemic sclerosis: recent advances
por: Ramos, Paula S., et al.
Publicado: (2015)

Syndecan-2 Is a Novel Target of Insulin-Like Growth Factor Binding Protein-3 and Is Over-Expressed in Fibrosis
por: Ruiz, Ximena D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qro213530ot4tm6055jivv9v8l